Potentiation of halofantrine-induced QTc prolongation by mefloquine: Correlation with blood concentrations of halofantrine

British Journal of Pharmacology

Volumn 132, Issue 1, 2001, Pages 197-204

  Lightbown, Ian D ^a   Lambert, James P ^a   Edwards, Geoffrey ^a,b   Coker, Susan J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Arrhythmias; AV block; Cardiotoxicity; Halofantrine; Mefloquine; QT prolongation; QTc interval

Indexed keywords

HALOFANTRINE; MEFLOQUINE;

ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG POTENTIATION; ELECTROCARDIOGRAPHY; FEMALE; LONG QT SYNDROME; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0035146025     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703823     Document Type: Article

References (30)

1. A model of myocardial ischemia for the simultaneous assessment of electrophysiological changes and arrhythmias in intact rabbits
2. Glibenclamide does not prevent action potential shortening induced by ischemia in anesthetized rabbits but reduces ischemia-induced arrhythmias
3. Comparison of the acute cardiotoxicity of the antimalarial drug halofantrine in vitro and in vivo in anaesthetized guinea-pigs
4. Halofantrine metabolism in microsomes in man: Major role of CYP 3A4 and CYP 3A5
5. Effect of selected antimalarial drugs and inhibitors of cytochrome P-450 3A4 on halofantrine metabolism by human liver microsomes
6. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: Experimental profile of BRL-32872
7. Prolonged QT interval with halofantrine
8. The antimalarial drug halofantrine is bound mainly to low and high density lipoproteins in human serum
9. Effects of mefloquine on cardiac contractility and electrical activity in vivo, in isolated cardiac preparations, and in single ventricular myocytes
10. QTc prolongation by desbutylhalofantrine, the metabolite of the antimalarial drug halofantrine
11. Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: A double-blind, placebo-controlled trial
12. Photoaffinitiy labeling of mefloquine-binding proteins in human serum, uninfected erythrocytes and Plasmodium falciparum-infected erythrocytes
13. Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: A doubleblind, placebo-controlled trial
14. An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: Studies with human liver microsomes and heterologous enzyme expression systems
15. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine
16. Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state
17. Cardiac effect of halofantrine
18. Metabolism of halofantrine to its equipotent metabolite, desbutylhalofantrine, is decreased when orally administered with ketoconazole
19. Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria
20. Effect of mefloquine on electrocardiographic changes in uncomplicated falciparum malaria patients
21. Mefloquine effect on disposition of halofantrine in the isolated perfused rat liver
22. Measurement of halofantrine and its major metabolite desbutylhalofantrine in plasma and blood by high-performance liquid chromatography: A new methodology
23. The missing second: What is the correct unit for the Bazett corrected QT interval?
24. Cardiac complications of halofantrine - A prospective-study of 20 patients
25. Prolonged QT interval with halofantrine
26. Cardiac effects of antimalarial treatment with halofantrine
27. Provocation of ventriculartachycardia by antimalarial drug halofantrine in congenital long QT syndrome
28. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria
29. Mechanism of cardiotoxicity of halofantrine
30. Kr. Implications for torsade de pointes and reverse use-dependence